This is a federal contract award from the Defense Logistics Agency (DLA) to Dakota Drug, Inc., a self-certified small disadvantaged business, for the delivery of pharmaceutical products, medical supplies, and healthcare equipment. The contract has a firm fixed price of $1,928.41 and a completion date of June 25, 2024. The contract is a delivery order under a larger Indefinite Delivery Contract (IDC) with the DLA, identified as SPE2DB24D8001, valued at $999,999,999.00. This IDC is part of the DLA...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to Dakota Drug, Inc., a self-certified small disadvantaged business. The contract, identified as SPE2DB24D8001, is part of the DLA Troop Support Medical's ECAT Generation V Program and has a ceiling value of $11,580.84. The contract is for the delivery of pharmaceutical products, medical supplies, and healthcare equipment to support U.S. Armed Forces medical operations. It is a firm fixed-price,...
This is a federal contract award issued by the Defense Logistics Agency (DLA) to Dakota Drug, Inc., a self-certified small disadvantaged business. The contract, identified as SPE2DB24D8001 and SPE2DB25FKZED, is a Delivery Order with a Firm Fixed Price pricing type. The contract has a ceiling value of $2,077.19 and an ultimate completion date of February 11, 2025. The contract is for the delivery of pharmaceutical products, medical supplies, and healthcare equipment, primarily to support U.S....
This federal contract was awarded by the Defense Logistics Agency (DLA) to Dakota Drug, Inc., a self-certified small disadvantaged business, for the delivery of pharmaceutical products, medical supplies, and healthcare equipment. The contract award, identified as SPE2DB24D8001, is a $999,999,999.00 Indefinite Delivery Contract (IDC) under the DLA Troop Support Medical's ECAT Generation V Program, which allows Dakota Drug, Inc. to provide a comprehensive range of medical items to support U.S....
This federal contract award, identified as SPE2DB24D8001|SPE2DB25FKYWG, was issued by the Defense Logistics Agency (DLA) to Dakota Drug, Inc., a self-certified small disadvantaged business. The contract, which is a Delivery Order under the DLA Troop Support Medical's ECAT Generation V Program, is for the delivery of pharmaceutical products, medical supplies, and healthcare equipment, including prescription medications, medical devices, vaccines, and other healthcare-related items. The contract...
The federal contract award SPE2DB24D8001 to Dakota Drug, Inc., a self-certified small disadvantaged business, provides for the delivery of pharmaceutical products, medical supplies, and healthcare equipment to the U.S. Department of Defense through the Defense Logistics Agency (DLA) Troop Support Medical program. This single-award Indefinite Delivery Contract (IDC), valued at $999,999,999.00, allows Dakota Drug, Inc. to supply a comprehensive range of critical medical items, including treatments...
This federal contract award was made by the Defense Logistics Agency (DLA) to Dakota Drug, Inc., a self-certified small disadvantaged business, to provide a variety of pharmaceutical products, medical supplies, and healthcare equipment to support U.S. Armed Forces medical operations. The contract, identified as SPE2DX15D8002|SPE2DX24F2UW2, has a ceiling value of $4,825.71 and is a Firm Fixed Price Delivery Order with a completion date of February 9, 2024. Dakota Drug, Inc. is a key supplier...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Dakota Drug, Inc., a self-certified small disadvantaged business. The contract is for the delivery of PROQUAD VIALS, a medical product, and has a ceiling value of $5,758.90. The contract is a Firm Fixed Price, Delivery Order type, with a period of performance through September 19, 2024. Dakota Drug, Inc. holds a significant single-award Indefinite Delivery Contract (IDC) with the DLA, identified as...
This is a delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical division to Dakota Drug, Inc., a self-certified small disadvantaged business, for the delivery of PROQUAD VIALS. The fixed-price contract has a ceiling value of $5,162.20 and a performance period through August 22, 2022. Dakota Drug, Inc. has a larger Indefinite Delivery Contract (IDC) with the DLA, valued at $999,999,999.00, as part of the ECAT Generation V Program to provide a range of pharmaceutical...
This federal contract award, identified as SPE2DB24D8001 and SPE2DB24FKYWA, was issued by the Defense Logistics Agency (DLA) to the prime contractor Dakota Drug, Inc. The contract is a single-award Indefinite Delivery Contract (IDC) valued at $999,999,999.00, which allows Dakota Drug, Inc. to provide a range of pharmaceutical products, medical supplies, and healthcare equipment to support U.S. Armed Forces medical operations. The contract falls under the DLA Troop Support Medical's ECAT...